dc.contributorHelton José dos Reis
dc.contributorhttp://lattes.cnpq.br/6160909637788264
dc.contributorAntônio Carlos Pinheiro de Oliveira
dc.contributorVanessa Gomes Fraga
dc.creatorFernanda Valadares Maciel
dc.date.accessioned2021-01-15T19:37:30Z
dc.date.accessioned2022-10-03T23:24:43Z
dc.date.available2021-01-15T19:37:30Z
dc.date.available2022-10-03T23:24:43Z
dc.date.created2021-01-15T19:37:30Z
dc.date.issued2018-06-29
dc.identifierhttp://hdl.handle.net/1843/34737
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3822137
dc.description.abstractAccording to the World Health Organization, neurological disorders such as Parkinson's disease (PD) account for more than 6% of the disease global burden. PD, discovered more than 200 years ago, is characterized by the progressive loss of dopaminergic neurons of the Substantia Nigra pars compacta (SNpc), causing an abnormality in movement control. Several factors may culminate in neurodegeneration, among them evidence suggests that neuroinflammation plays an important role. Although brain inflammatory response is potentially beneficial, recent studies suggest that it can cause progressive degeneration of dopaminergic neurons. Thus, in order to delay the neurodegenerative process, the repositioning of non-steroidal anti-inflammatory drugs (NSAIDs) to treat PD has been investigated. This study analyzed bibliographies referring to the subject in order to verify if NSAIDs produce positive results in the reduction of neurodegeneration in PD.
dc.publisherUniversidade Federal de Minas Gerais
dc.publisherBrasil
dc.publisherICB - DEPARTAMENTO DE FARMACOLOGIA
dc.publisherCurso de Especialização em Farmacologia
dc.publisherUFMG
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/pt/
dc.rightsAcesso Aberto
dc.subjectDoença de Parkinson
dc.subjectNeurodegeneração
dc.subjectNeuroinflamação
dc.subjectReposicionamento de fármacos
dc.subjectAnti-inflamatórios não esteroides
dc.titleReposicionamento de fármacos na doença de Parkinson: anti-inflamatórios não esteroides como potenciais fármacos para minimizar a neurodegeneração.
dc.typeMonografia (especialização)


Este ítem pertenece a la siguiente institución